Jl Looi

Use of Secondary Prevention Medication Before and After an Acute Coronary Syndrome: Potential Long-Term Community Improvements, But Is This as ‘Good as it Gets’ After Hospital Discharge?

Improved Door to Reperfusion Time (DTRT) for ST Elevation Myocardial Infarction (STEMI) Patients Receiving Primary Percutaneous Coronary Intervention (PPCI) in Central Auckland: 2006–2007 to 2012

Primary Percutaneous Coronary Intervention (PPCI) for ST Segment Elevation Myocardial Infarction (STEMI) Patients: The 2012 Auckland/Northland Experience

Primary Percutaneous Coronary Intervention for Patients with St Elevation Myocardial Infarction—Past and Present at Auckland City Hospital

Primary Percutaneous Coronary Intervention for All Patients with ST Elevation Myocardial Infarction—The Initial Experience at Auckland City Hospital 2006/2007

ST Elevation Myocardial Infarction: Suboptimal Use of Secondary Prevention Medications at Review Five Years Later

ST Elevation Myocardial Infarction Patients have poor Cholesterol Control and Significant Adverse Events at Review Four Years Later

Acute Coronary Syndrome Patients Treated with CABG Surgery: Suboptimal Use of Secondary Prevention Medications at Review 3 Years Later

The Progression of ECG Changes in Apical Ballooning Syndrome Compared with Non-ST Elevation Myocardial Infarction (NSTEMI)

High Mortality and Morbidity in Acute Coronary Syndrome Patients who Received Medical (Non-revascularisation) Management